Allen's son, Wesley, was diagnosed with acute promyelocytic leukemia in January 2025. Hines-Allen missed a game d ...

Jacksonville Jaguars DE Josh Hines-Allen disclosed his son's pediatric cancer diagnosis and his campaign for cancer-related ...

Jacksonville Jaguars DE Josh Hines-Allen gave insight to how he and his family handled his son's cancer diagnosis.

Jacksonville Jaguars defensive end Josh Hines-Allen announced Friday that his 7-year-old son, Wesley, is recovering from ...

Jacksonville Jaguars defensive end Josh Hines-Allen announced Friday that his 7-year-old son, Wesley, is recovering from ...

Jaguars defensive end Josh Hines-Allen said his seven-year-old son, Wesley, is in remission after fighting acute ...

Acute promyelocytic leukaemia (APL) represents a unique and once highly fatal subtype of acute myeloid leukaemia that is now considered among the most curable forms of haematological malignancies ...

But, I think now, I would say yes ... it should be the new standard of care." APL is a rare and distinct subtype of acute myeloid leukemia, with fewer than 1,000 cases diagnosed in the U.S. each year.

Purpose: To analyze patient cases of therapy-related acute promyelocytic leukemia (tAPL), occurring after chemotherapy (CT), radiotherapy (RT) or both for a prior disorder, diagnosed during the last ...

RESULTS: Thirty-four patients (85%) achieved a CR. Thirty-one patients (91%) with CRs had posttreatment cytogenetic tests negative for t (15;17). Eighty-six percent of the patients who were assessable ...

Nier S, Chowdbury S, Skedgel C, Mott D. Understanding the preferences of people with acute leukemia for different health outcomes. Presented at: EHA2025 Congress; June 12-15, 2025; Milan, Italy.